Trial intelligence / Profile preview

Proellex extension in endometriosis

NCT00958412Phase 2Terminated

Sponsor
Repros Therapeutics Inc.
Start
Feb 2009
Primary completion
Aug 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of telapristone in endometriosis, sponsored by Repros Therapeutics Inc.. Started Feb 2009; status: terminated.

02

Drugs

telapristone
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT00958412.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00958412.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call